Bayer AG (BAYGn.DE)

BAYGn.DE on Xetra

95.41EUR
15 Aug 2014
Price Change (% chg)

€-2.28 (-2.33%)
Prev Close
€97.69
Open
€97.78
Day's High
€98.45
Day's Low
€95.03
Volume
2,510,992
Avg. Vol
2,147,231
52-wk High
€114.20
52-wk Low
€88.50

BAYGn.DE

Chart for BAYGn.DE

About

Bayer AG is a German holding company active in the field of health care, nutrition and high-tech materials. It has three subgroups: HealthCare, involved in the research, development and production of health products for people and animals, CropScience, engaged in the crop protection and non-agricultural pest control, and... (more)

Overall

Beta: 0.90
Market Cap (Mil.): €86,705.48
Shares Outstanding (Mil.): 826.95
Dividend: 2.10
Yield (%): 2.00

Financials

  BAYGn.DE Industry Sector
P/E (TTM): 24.33 32.64 33.19
EPS (TTM): 4.31 -- --
ROI: 9.08 18.40 17.65
ROE: 18.35 19.06 18.46
Search Stocks

Data, IMF outlook point to German economy running out of steam

BERLIN - German industrial output in August plunged at its steepest rate since the height of the financial crisis, data showed on Tuesday, while the International Monetary Fund cut its German growth forecast.

07 Oct 2014

Fears of rising rates fade in high-grade bond market

NEW YORK, Oct 3 (IFR) - Fears that rising US rates will sound the death knell for bonds are fading, following the past week's extraordinary performance of acquisition financings in the investment grade new issue market from names like Bayer.

03 Oct 2014

BRIEF-Bayer successfully places $7 bln jumbo bond

* Net cash provided by the bond will replace part of bridge financing secured in connection with takeover of Merck & Co's OTC unit Source text: http://bit.ly/1vzhWkb Further company coverage:

02 Oct 2014

Bayer launches US$7bn six-tranche acquisition bond

NEW YORK, Oct 1 (IFR) - Bayer launched a US$7bn six-tranche acquisition bond financing for Merck's consumer care business Wednesday at levels 10bp-25bp inside of initial price thoughts, leads on the trade said.

01 Oct 2014

BRIEF-Bayer completes takeover of Merck & Co OTC drug unit

* Completes takeover of merck & co otc drug unit Further company coverage:

01 Oct 2014

BRIEF-Bayer closes buy of Merck & Co consumer care business

* Says bayer closes acquisition of consumer care business of merck & co., inc., united states, for usd 14.2 billion

01 Oct 2014

BRIEF-Bayer Cropscience says to buy seed business of Granar SA

* Cropscience announced today that it has entered into an agreement to purchase seed business of Granar S.A.

01 Oct 2014

Bayer names Frank Lutz as MaterialScience CFO

FRANKFURT, Sept 23 - Germany's Bayer named Frank Lutz as chief financial officer of its plastics unit MaterialScience, which it plans to float on the stock market as a separate company.

23 Sep 2014

Bayer asks Rothschild to advise on plastics business flotation: sources

FRANKFURT/LONDON - Bayer has appointed investment bank Rothschild [ROT.UL] to advise on the German drugmaker's plan to list its plastics business, in a deal that could value the unit at about 10 billion euros ($13 billion), sources familiar with the situation said.

22 Sep 2014

Bayer asks Rothschild to advise on plastics business flotation-sources

FRANKFURT/LONDON, Sept 22 - Bayer has appointed investment bank Rothschild to advise on the German drugmaker's plan to list its plastics business, in a deal that could value the unit at about 10 billion euros ($13 bln), sources familiar with the situation said.

22 Sep 2014

Earnings vs. Estimates

Analyst Research Reports

Report Title Price
Provider: Reuters Investment Profile
$20.00
Provider: Reuters Investment Profile
$20.00
Provider: Ford Investor Services, Inc.
$12.00
Provider: GlobalData
$125.00
Provider: ValuEngine, Inc.
$25.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Search Stocks